Case Reports in Oncology (Dec 2010)

Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer

  • Muge Akmansu,
  • Suleyman Buyukberber,
  • Sevilay Iren,
  • Umut Demirci,
  • Gul Kanyilmaz,
  • Ugur Coskun,
  • Huseyin Bora

DOI
https://doi.org/10.1159/000323204
Journal volume & issue
Vol. 3, no. 3
pp. 480 – 488

Abstract

Read online

We presented 9 recurrent head and neck carcinoma patients. Priorly all of them had received radiochemotherapy. We used cetuximab and irradiation concomitantly. Overall survival analysis of the patients was performed using the Kaplan-Meier method on SPSS version 15.0. Based on this calculation, mean follow-up duration is 12.8 months. Mean survival time is 19.8 months and annual mean survival rate is 59.3%.

Keywords